Mayne Pharma Group Ltd (MYX)

Currency in AUD
5.180
+0.030(+0.58%)
Closed·
MYX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MYX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.1005.200
52 wk Range
3.7707.310
Key Statistics
Bid/Ask
5.11 / 5.20
Prev. Close
5.15
Open
5.14
Day's Range
5.1-5.2
52 wk Range
3.77-7.31
Volume
92.29K
Average Volume (3m)
561.96K
1-Year Change
29.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.750
Upside
+30.31%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Mayne Pharma Group Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Mayne Pharma Group Ltd Company Profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women’s Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Employees
967
Market
Australia

Compare MYX to Peers and Sector

Metrics to compare
MYX
Peers
Sector
Relationship
P/E Ratio
−3.5x7.9x−0.6x
PEG Ratio
−0.080.000.00
Price/Book
0.9x5.6x2.6x
Price / LTM Sales
1.0x5.8x3.3x
Upside (Analyst Target)
31.1%65.5%39.1%
Fair Value Upside
Unlock5.1%4.5%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.750
(+30.31% Upside)

Earnings

Latest Release
Apr 21, 2025
EPS / Forecast
-0.25 / --
Revenue / Forecast
86.80M / --
EPS Revisions
Last 90 days

MYX Income Statement

People Also Watch

218.770
MQG
+0.71%
90.090
WES
-0.36%
0.440
CMW
0.00%

FAQ

What Stock Exchange Does Mayne Pharma Trade On?

Mayne Pharma is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Mayne Pharma?

The stock symbol for Mayne Pharma is "MYX."

What Is the Mayne Pharma Market Cap?

As of today, Mayne Pharma market cap is 420.85M.

What Is Mayne Pharma's Earnings Per Share (TTM)?

The Mayne Pharma EPS (TTM) is -1.49.

When Is the Next Mayne Pharma Earnings Date?

Mayne Pharma will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is MYX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Mayne Pharma Stock Split?

Mayne Pharma has split 4 times.

How Many Employees Does Mayne Pharma Have?

Mayne Pharma has 967 employees.

What is the current trading status of Mayne Pharma (MYX)?

As of 19 Aug 2025, Mayne Pharma (MYX) is trading at a price of 5.18, with a previous close of 5.15. The stock has fluctuated within a day range of 5.10 to 5.20, while its 52-week range spans from 3.77 to 7.31.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.